跳至主要内容
临床试验/ITMCTR2100005326
ITMCTR2100005326尚未招募1 期

Oral Tanshinone in the treatment of dry eyes associated with rosacea

The Second Affiliated Hospital of Fujian Medical University0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Treatment study

入排标准

年龄范围
18 至 60(—)
性别
All

入选标准

  • This study included patients who were diagnosed with rosacea at the dermatology clinic and met the ophthalmologic assessment for dry eye.

排除标准

  • 1.Trichiasis, eyelid abnormalities, lacrimal diseases, glaucoma or Uveitis, and other ophthalmic emergencies;
  • 2.Other conjunctival or ocular surface diseases, such as conjunctival cyst, conjunctival pemphigoid, conjunctival relaxation, limbal stem cell deficiency, etc.
  • 3.long-term use of topical drugs in addition to artificial tears, such as anti-glaucoma drugs, immunosuppressants, etc.
  • 4.History of ocular trauma, eyelid, ocular surface, glaucoma and internal eye surgery;
  • 5.Severe liver and kidney dysfunction, Coagulopathy, or other serious diseases may affect drug efficacy;
  • 6.Pregnant women;
  • 7.The researchers concluded that there were any conditions that were not suitable for participation in the trial.

研究者

发起方
The Second Affiliated Hospital of Fujian Medical University

相似试验